From the ∗Department of Internal Medicine II, Gastroenterology
†European Neuroendocrine Tumor Society Center of Excellence (ENETS CoE), NET Zentrum Würzburg
‡Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany
§Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
∥Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD.
Received for publication July 25, 2022; revision accepted November 14, 2022.
Conflicts of interest and sources of funding: R.A.W. has received speaker's honoraria from Advanced Accelerator Applications. This project was partially supported by the Okayama University “RECTOR” Program (T.H.) and the German Research Foundation (507803309, R.A.W.; 453989101, R.A.W., T.H.). T.H. received a KAKENHI grant (21K19450) from the Japan Society for the Promotion of Science. The other authors have none declared.
Correspondence to: Rudolf A. Werner, MD, Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080 Würzburg, Germany. E-mail: [email protected].
